Memorial Sloan Kettering Cancer Center Y M Abs Therapeutics, Inc. Transaction History
Memorial Sloan Kettering Cancer Center
- $24.6 Million
- Q3 2023
A detailed history of Memorial Sloan Kettering Cancer Center transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Memorial Sloan Kettering Cancer Center holds 191,176 shares of YMAB stock, worth $2.78 Million. This represents 4.24% of its overall portfolio holdings.
Number of Shares
191,176
Previous 191,176
-0.0%
Holding current value
$2.78 Million
Previous $1.3 Million
19.8%
% of portfolio
4.24%
Previous 4.1%
Shares
2 transactions
Others Institutions Holding YMAB
# of Institutions
97Shares Held
23.8MCall Options Held
19.4KPut Options Held
300-
Paradigm Biocapital Advisors LP New York, NY3.87MShares$56.4 Million1.89% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$42.8 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$31.9 Million1.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$28.5 Million0.0% of portfolio
-
Polar Capital Holdings PLC London, X01.83MShares$26.7 Million0.13% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $637M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...